Given that the dearth of new antibiotic development loads an existential burden on successful infectious disease therapy 1 , health organizations are calling for alternative approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) infections. Here, we report a drug-free photonic approach to eliminate MRSA through photobleaching of staphyloxanthin, an indispensable membrane-bound antioxidant of S. aureus 2-5 . The photobleaching process, uncovered through a transient absorption imaging study and quantitated by absorption spectroscopy and mass spectrometry, decomposes staphyloxanthin and sensitizes MRSA to reactive oxygen species attack. Consequently, staphyloxanthin bleaching by low-level blue light eradicates MRSA synergistically with external or internal reactive oxygen species. The effectiveness of this synergistic therapy is validated in MRSA culture, MRSA-infected macrophage cells, S. aureus biofilms, and a mouse wound infection model. Collectively, these findings highlight broad applications of staphyloxanthin photobleaching for treatment of MRSA infections.
Given that the dearth of new antibiotic development loads an existential burden on successful infectious disease therapy 1 Staphylococcus aureus causes a variety of diseases ranging from skin and soft tissue infections to life-threatening septicemia [6] [7] [8] [9] . Moreover, S. aureus has acquired resistance to multiple antibiotic classes that were once effective 10 . A classic example is the emergence of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) strains in the 1960s that exhibited resistance to ߚ -lactam antibiotics [11] [12] [13] . More recently, strains of MRSA have exhibited reduced susceptibility to newer antibiotics such as daptomycin and antibiotics deemed agents of last resort such as vancomycin and linezolid 14, 15 . Besides the acquired resistance through mutational inactivation, MRSA develops other strategies, e.g. residing inside host immune cells or forming biofilms, to evade the effect of antibiotics. Those strategies pose an appalling challenge to the successful therapy for MRSA infections.
Initially we attempted to differentiate MRSA from methicillin-susceptible S. aureus by transient absorption imaging (see Methods and Supplementary Fig. 1 ) of their intrinsic chromophores. Intriguingly, once the cultured S. aureus was placed under the microscope, the strong signal measured at zero delay between the 520-nm pump and 780-nm probe pulses quickly attenuated over second time scale ( Fig. 1a and Supplementary Video 1). We hypothesized that a specific chromophore in S. aureus is prone to photobleaching under the abovementioned setting. To verify the photobleaching phenomenon, we fitted the time-course curve with a photobleaching model 16 (Fig. 1b showed negligible effect on the bleaching speed (߬ ଶ = 0.14 ± 0.01 s, Supplementary Fig. 3a ). The same phenomenon was observed in methicillin-susceptible S. aureus ( Supplementary Fig. 3b ).
Collectively, these data support a second-order photobleaching process.
Next, we aimed to deduce the specific chromophore inside S. aureus that accounts for the observed photobleaching phenomenon. It is known that carotenoids are photosensitive due to the conjugated C=C bonds 17, 18 . Therefore, we hypothesized that staphyloxanthin (STX), a carotenoid pigment residing in the cell membrane of S. aureus, underwent photobleaching in our transient absorption study. To test this hypothesis, we treated MRSA with naftifine, a FDA-approved antifungal drug that blocks the synthesis of STX 3 . The treated MRSA exhibited lower signal intensity ( Fig. 1c ) and slower photobleaching speed ( Fig. 1d ). Specifically, ߬ ଶ of naftifine-treated MRSA (0.39 ± 0.07 s) is 2.5 times of that of MRSA (0.15 ± 0.02 s), in consistence with secondorder photobleaching. Furthermore, no transient absorption signal was observed in a S. aureus stain containing a mutation in dehydrosqualene synthase (CrtM) ( Fig. 1e ) that is responsible for STX biosynthesis 19 . To avoid the systematic error aroused by single bacterium measurement, we repeated the same analysis using bacterial colonies. It turned out that CrtM-mutant colony ( Fig.   1f ,h) only exhibited background induced by cross-phase modulation 20 , whereas the MRSA colony showed a sharp contrast against the background (Fig. 1g ) and a fast photobleaching decay ( Fig. 1h ). Taken together, these data confirm that STX in S. aureus accounts for the observed photobleaching.
In the transient absorption study, when changing 520-nm pump irradiance while fixing 780-nm probe intensity, both signal intensity and ߬ ଶ changed drastically ( Supplementary Fig.   4a ,c), whereas the alteration of probe irradiance only affected the transient absorption signal intensity but not ߬ ଶ ( Supplementary Fig. 4b,d ). These findings collectively imply that photobleaching efficacy is highly dependent on the excitation wavelength ( Supplementary Fig.   4e ), which is consistent with the fact that photobleaching is grounded on the absorption of chromophore 21 .
To find the optimal wavelength for bleaching STX, we measured the absorption spectrum of crude STX extract from S. aureus. The extract shows strong absorption in the window from 400 nm to 500 nm ( Fig. 2a ). Based on this result, we built a portable device composed of a blue light-emitting diode (LED) with central emission wavelength around 460 nm for wide-field bleaching of STX ( Fig. 2a and Supplementary Fig. 5 ). We exposed the crude STX extract to blue light (90 mW) for different time intervals. Remarkably, the distinctive golden color of STX disappeared within 30-min exposure, whereas the control group under ambient light remained unchanged ( Fig. 2b ). Its absorption peak between 400 and 500 nm decreased dramatically over blue light exposure time (Fig. 2c ). The optical density (OD) at 470 nm (from Fig. 2c ) versus the blue light dose can be well fitted with equation (1) ( Fig. 2d ). Additionally, naftifine-treated or CrtM-mutant MRSA extracts were insensitive to blue light exposure, indicated by their nearly unchanged absorption spectra ( Supplementary Fig. 6a -c). These findings collectively suggest that STX is prone to bleaching under blue light irradiance.
To quantitate the photobleaching process, we studied STX degradation induced by blue light irradiation by mass spectrometry (MS). Supplementary Fig. 7 presents the MS spectrum of S. aureus extract with m/z ranging from 200 to 1000 eV at a collision energy of 10 eV. An abundant peak appears at m/z = 721.5, while a weaker peak at m/z = 819.5 ([M+H + ]) is consistent with the molecular weight of STX (M w = 818.5 g/mol). To find out the relationship between m/z = 721.5 and m/z = 819.5, we gradually increased the collision energy from 0 to 20 eV. In Fig. 2e , the abundance of m/z = 721.5 increases relative to that of m/z = 819.5 with increasing collision energy, which indicates m/z =721.5 is a product ion from m/z = 819.5. These data also prove that STX is the major species in S. aureus extract. When the collision energy was higher than 30 eV, m/z = 241.5, a product of the precursor ion m/z = 721.5, became dominant and presented as a stable marker ( Fig. 2e ). Thus, to accurately quantify the amount of STX versus blue light dose, we targeted the peak area in high-performance liquid chromatography (HPLC) spectra specifically from ion m/z = 241.5 ( Fig. 2f ). Figure 2h ), which is an adjunct between STX and Na + . Degradation of STX would bolster the aggregation of chemical segments. Accordingly, we screened a patch of the products after STX photobleaching ( Supplementary Fig. 8 ). In particular, the intensity of the peak at m/z = 643.5
representing an adjunct between a STX segment with H + , significantly increased as blue light exposure elongates ( Fig. 2i ). Figure 2j illustrates how this segment is formed from breakdown of one C=C bond in STX during blue light bleaching. We note that interpretation of other products ( Supplementary Fig. 8a -i) necessitates further in-depth analysis.
Given STX is critical to the integrity of S. aureus cell membrane 19 , we questioned whether blue light alone could eradiate MRSA through bleaching STX. Blue light at 405-420 nm has been used for MRSA suppression 22 . Yet the efficacy is limited and the molecular mechanism remain elusive. Here, we show that STX is the molecular target of blue light irradiation. We find that increasing blue light dose steadily decreased the level of MRSA CFU (Fig. 3a ). Moreover, MRSA was more sensitive to blue light exposure than the CrtM mutant ( Supplementary Fig. 9 ).
Nevertheless, the positive impact on the reduction of CFU did not improve when the blue light dose exceeded 216 J/cm 2 with 60-min exposure time ( Fig. 3a) . To investigate the reason, we continuously monitored the growth of MRSA in fresh medium after 10-min blue light exposure.
Remarkably, MRSA exposed to blue light was able to recover and multiply after being cultured in medium ( Fig. 3b ). Therefore, photobleaching STX alone is not sufficient to kill MRSA completely.
Considering that STX serves as an indispensable antioxidant for MRSA, we then explored whether photobleaching of STX could sensitize MRSA to reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 ). We examined the viability of MRSA exposed to H 2 O 2 after blue light exposure. When MRSA was treated with blue light (dose: 108 J/cm 2 ) followed by an increasing concentration of H 2 O 2 , a significant reduction (p < 0.001) in CFU was obtained Noteworthy, this treatment did not affect other species of staphylococci, such as S. epidermidis ( Fig. 3e Fig. 3g ). Figure 3h compiled the statistical analysis of different groups. Notably, a nearly one-log 10 reduction in CFU was found in the blue lighttreated group in comparison to the untreated. On the contrary, vancomycin was unable to eradicate intracellular MRSA. Additionally, we found that whole blood could eradicate most of MRSA after STX bleaching by blue light ( Supplementary Fig.10 ). These findings collectively suggest that blue light is capable of assisting neutrophils to eradicate intracellular MRSA.
Besides residing inside host immune cells, S. aureus is capable of forming biofilms. Due to difficulties for antibiotics to penetrate the matrix of biofilm termed extracellular polymeric substance 24 , bacterial biofilms present a significant source of treatment failure and recurring infection in patients 24 . Compared to antibiotics, an unparalleled advantage of our photobleaching therapy lies in the fact that photons can readily penetrate through a cell membrane or a biofilm, or even a layer of tissue. To explore whether STX bleaching could eradicate S. aureus inside biofilm, we grew biofilms on the bottom of glass dish and then applied blue light or daptomycin (positive control) to the biofilms. Supplementary Fig. 11 These results suggest an effective way to eradicate sessile bacterial cells inside biofilms.
The promising results obtained from the intracellular infection and biofilm studies led us to evaluate the efficacy of STX photobleaching in a MRSA-infected animal model. Skin infections such as diabetic foot ulceration and surgical site infections 25 are common causes of morbidity in healthcare settings. Notably, S. aureus accounts for 40% of these infections 26 . To optimize the parameters for the in vivo experiment, we initially proved that 2-min blue light exposure (dose: 24 J/cm 2 ) could cause significant reduction in survival percent of MRSA ( Supplementary Fig. 12a ). Then, two times antimicrobial efficiency was obtained when cultured ( Supplementary Fig. 12b ), which facilitates us to apply treatment in MRSA-infected animal model.
To induce skin lesions in mice, we severely irritated mice skin (5 groups; 5 mice per group) by an intradermal injection containing 10 8 CFU of MRSA USA300 (Fig. 4a ), the leading source of S. aureus induced skin and soft tissue infections in North America 27 . Sixty hours post
injection, an open wound formed at the site of infection (Fig. 4b (top) ). Topical treatments were subsequently administered to each group, twice daily for three consecutive days. All the treated groups appeared healthier compared to the control group (Fig. 4b (middle) ). Then, mice were humanely euthanized and wounds were aseptically removed in order to quantify the burden of MRSA in wounds (see Methods). We further examined the physiological condition of the wounds. The untreated, fusidic acid-treated (positive control), and blue light-treated groups all showed the formation of pus below the wound, most likely due to inflammatory response. In contrast, mice receiving only H 2 O 2 or blue light plus H 2 O 2 treatment exhibited clean wounds that were free of purulent material, swelling, and redness around the edge of the wound (Fig. 4b (bottom)). Notably, the blue light dosage applied to treat mouse wound infection was below the ANSI safety limit for skin exposure 28 .
To In order to quantify the burden of MRSA in wounds, homogenized wound tissue solution was inoculated onto mannitol salt agar plates (MRSA specific). Remarkably, the blue light plus H 2 O 2 -treated group showed 1.5-log 10 reduction of CFU compared to the untreated group (Fig.   4d ). Statistical analysis of CFU from the blue light plus H 2 O 2 -treated group depicted significant MRSA reduction compared to other groups (Fig. 4e) . Noteworthy, the blue light plus H 2 O 2treated group showed one-log 10 more reduction than the fusidic acid-treated group (Fig. 4e ). It is worth noting that pigment is a hallmark feature of multiple pathogenic microbes 30 . Taken together, our findings show the exciting potential of treating drug-resistant bacteria by exploiting the unique photochemistry of their intrinsic pigments.
Materials and methods

Transient absorption microscope
An optical parametric oscillator synchronously pumped by a femtosecond pulsed laser generates pump (1040 nm) and probe (780 nm) pulse trains ( Supplementary Fig. 1 ). The pump (1040 nm) is then frequency-doubled (second harmonic generation (SHG) process) to 520 nm µ L methanol at 55 °C for 20 minutes. Pigments from the CrtM mutant were extracted by the same method. The protocol for the treatment of S. aureus with naftifine was adapted from a published report 3 . Bacteria were cultured with 0.2 mM naftifine for 24 hours at 37°C with the shaking speed of 250 rpm. The extraction procedure was the same as described above. The extracted solutions were subsequently exposed to blue light (90 mW, aperture: 1 cm × 1 cm) at different time intervals (0 min, 5 min, 10 min, 20 min). Absorption spectra of the above solutions were obtained by a spectrometer (SpectraMax, M5).
Mass spectrometry
To study the photobleaching effect on STX, we extracted crude STX from S. aureus and exposed the extract to blue light using the procedure described above. The separation was 
